PAVmed Inc. PAVM
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -8,873.33% | 95.25% | 76.54% | 54.84% | -162.85% |
| Total Depreciation and Amortization | -5.00% | 11.11% | -18.18% | 0.00% | -48.84% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 207.28% | -430.98% | -111.23% | -59.79% | 152.57% |
| Change in Net Operating Assets | -46.15% | -114.86% | -3.85% | 163.77% | 121.04% |
| Cash from Operations | -1.64% | -68.92% | -73.10% | 23.94% | 25.49% |
| Capital Expenditure | 40.91% | -57.14% | -366.67% | 62.50% | -33.33% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 40.91% | -57.14% | -366.67% | 62.50% | -33.33% |
| Total Debt Issued | -100.00% | -- | -- | -- | -- |
| Total Debt Repaid | 100.00% | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -100.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -100.00% | -- | -- | -- | -- |
| Repurchase of Preferred Stock | 100.00% | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | 100.00% | -100.08% | 2,384.40% |
| Cash from Financing | -100.00% | -- | 100.00% | -100.08% | -19.73% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -154.37% | 414.50% | -73.70% | -169.10% | -13.93% |